Dow Up 0.51% Nasdaq Up 0.24%

Omeros Corporation (OMER)

-NasdaqGM
20.12 Down 0.52(2.52%) Nov 21, 4:00PM EST
Prev Close:20.64
Open:20.99
Bid:18.79 x 100
Ask:20.27 x 200
1y Target Est:36.20
Beta:2.65
Next Earnings Date:N/A
Day's Range:20.01 - 21.17
52wk Range:7.00 - 22.46
Volume:426,975
Avg Vol (3m):415,029
Market Cap:685.59M
P/E (ttm):N/A
EPS (ttm):-1.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMERDown 2.52%685.59M
ACADUp 2.49%2.84B
ALKSUp 2.09%8.25B
HRTXUp 2.03%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,332.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.15
Quarterly EPS Est (Dec-14) :-0.64
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback